L
Lantern Pharma Inc. (LTRN)
NCM – Real Time Price. Currency in USD
1.12
-0.97 (-46.41%)
At close: Mar 27, 2026, 4:00 PM EDT
1.28
+0.16 (14.29%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
1.12
-0.97 (-46.41%)
At close: Mar 27, 2026, 4:00 PM EDT
1.28
+0.16 (14.29%)
After-hours: Mar 27, 2026, 7:59 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.33 | 6.05 | 10 | |
| Quick ratio | 3.33 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -97K | -155K | -175K | -190K | -64K |
| Operating Income | -13M | -14M | -18M | -22M | -20M |
| Net Income | -12M | -14M | -16M | -21M | -19M |
| EBITDA | -12M | -14M | -18M | -22M | -20M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 14.81 | 4.5 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | 13.47 | 4.5 |
| Next year | N/A | -14.37 | 1.0 |
| Weighted average score | 2.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 3.55 | 2.5 | -16.12 | 4.5 |
| Y/Y | 999 | 7.29 | 7.14 | 18.13 | 7.3 |
| 3y average | 999 | -19.14 | -19.79 | -18.98 | 3.3 |
| 5y average | 999 | -61.99 | -10.46 | -61.94 | 3.3 |
| Weighted average score | 4.6 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $8.4M significantly exceed its total debt $94.0K, ensuring strong financial flexibility
Total current assets $13.5M exceed Total current liabilities $4.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$4.6M limits the company's ability to reinvest or pay down debt